Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/17/2010US20100152151 Tgr5 modulators and methods of use therof
06/17/2010US20100152150 The application of marine steroid in preparing the medicine of treating neurons damaging
06/17/2010US20100152149 Formulation
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152147 Compositions Comprising Azelastine and Methods of Use Thereof
06/17/2010US20100152146 Topical Administration of Danazol
06/17/2010US20100152145 Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
06/17/2010US20100152144 Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
06/17/2010US20100152143 Methods of Treating Skin Disorders with Caffeic Acid Analogs
06/17/2010US20100152142 Crystalline form ii of tigecycline and processes for preparation thereof
06/17/2010US20100152141 Combinations comprising 5ht6 modulators and cholinesterase inhibitors
06/17/2010US20100152140 Method of Cancer Treatment with Naphthol Analogs
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/17/2010US20100152136 TP53 Gene expression and uses thereof
06/17/2010US20100152133 Use of chitosans to increase nail growth rate
06/17/2010US20100152132 Use of a Composition Comprising an Antacid, a Mucolytic and a Gelling Agent in the Treatment of Cold
06/17/2010US20100152131 Method for producing purified hematinic iron-saccharadic complex and product produced
06/17/2010US20100152130 Treatment of cancer with glutamine
06/17/2010US20100152129 Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer
06/17/2010US20100152128 Antiviral Agents
06/17/2010US20100152127 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
06/17/2010US20100152126 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
06/17/2010US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases
06/17/2010US20100152124 Use of hederagenin 3-0 alpha-l-rhamnopyranosyl(1-2)-(beta-d-glucopyranosyl(1-4)-alpha-l-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
06/17/2010US20100152123 Methods and compositions for treating disorders caused by a deficiency in a gene product of a cln gene
06/17/2010US20100152122 Oligo-guluronate and galacturonate compositions
06/17/2010US20100152121 Iodo-Hexose Compounds Useful to Treat Cancer
06/17/2010US20100152120 Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
06/17/2010US20100152112 Quinoline derivatives as p13 kinase inhibitors
06/17/2010US20100152108 Methods and combination therapies for treating alzheimer's disease
06/17/2010US20100152105 Use of rapamycin derivatives in chronic rejection
06/17/2010US20100152101 Triazol compounds for treating biofilm formation
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100152096 Formulations for parenteral administration of amino-substituted (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones
06/17/2010US20100152095 Wound healing
06/17/2010US20100151588 Means and methods for diagnosing and treating cancer based on the frmd3 gene
06/17/2010US20100151507 Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same
06/17/2010US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna
06/17/2010US20100151066 Composition for suppressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect
06/17/2010US20100151064 Thiazolhydrazides for treatment of neurodegenerative diseases
06/17/2010US20100151062 Determining nutrients for animals through gene expression
06/17/2010US20100151061 Methods of using benfotiamine and pyridoxamine compositions
06/17/2010US20100151058 Compositions for producing satiety
06/17/2010US20100151055 Aroma Composition to Reduce or Suppress Undesirable Bitter and Astringent Taste Impressions of Sweeteners
06/17/2010US20100151051 Anti-tumor drug, medicament, composition, and use thereof
06/17/2010US20100151045 Composition and method for reducing side-effects of indole-3-carbinol and derivatives
06/17/2010US20100151042 Materials and Methods for Treating Influenza Infections
06/17/2010US20100151037 Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
06/17/2010US20100151035 Pharmaceutical compositions of poorly soluble drugs
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151029 Anti-infectious hydrogel compositions
06/17/2010US20100151028 Crush resistant delayed-release dosage forms
06/17/2010US20100151027 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
06/17/2010US20100151024 Therapeutic agent for ulcerative colitis
06/17/2010US20100151021 Compositions Comprising Melperone
06/17/2010US20100151020 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
06/17/2010US20100151019 SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW pH AND METHODS OF USE THEREOF
06/17/2010US20100151018 Sustained-release levetiracetam composition and preparation process
06/17/2010US20100151016 Method for producing pharmaceutical tablet
06/17/2010US20100151015 Compositions Comprising Melperone and Controlled-Release Dosage Forms
06/17/2010US20100151013 Gastric acid secretion inhibiting composition
06/17/2010US20100151012 Stabilised pharmaceutical composition containing pregabaline
06/17/2010US20100151011 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
06/17/2010US20100151010 Medicament in a multilayer form
06/17/2010US20100151009 Formulations for delivering insulin
06/17/2010US20100151008 Preparations and Methods for Textile and or Fiber Surface Finishing, Surface Finished Articles Prepared Thereby, and Uses Therefor
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100151006 Cancer therapy sensitizer
06/17/2010US20100151005 Targeted carriers for intracellular drug delivery
06/17/2010US20100151004 Modulation of drug sensitivity
06/17/2010US20100151002 Guggulphospholipid Methods and Compositions
06/17/2010US20100151001 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
06/17/2010US20100150996 Athletic patch
06/17/2010US20100150995 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
06/17/2010US20100150993 Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement
06/17/2010US20100150992 Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue
06/17/2010US20100150986 Film preparation with rapidly dissolving property and flexibility
06/17/2010US20100150976 Biologically degradable multilayer system
06/17/2010US20100150970 Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction
06/17/2010US20100150947 Tolerance induction and maintenance in hematopoietic stem cell allografts
06/17/2010US20100150944 Methods and compositions for diagnosis and treatment of depression and anxiety
06/17/2010US20100150938 Methods and compositions for reducing inflammation and treating inflammatory disorders
06/17/2010US20100150930 Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010US20100150924 Regulation of myelination by nectin-like (necl) molecules
06/17/2010US20100150922 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
06/17/2010US20100150913 Organic compounds
06/17/2010US20100150911 Methods and systems of treating age-related macular-degeneration
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150899 Pyrazolinone scavengers of free radical
06/17/2010US20100150898 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
06/17/2010US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010US20100150895 Nutraceutical agent for attenuating the Neurodegenerative process associated with Parkinson's disease
06/17/2010US20100150894 Composition for prevention of cancer
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150891 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
06/17/2010US20100150890 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
06/17/2010US20100150881 Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces
06/17/2010US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases
1 ... 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 ... 7860